Yeah
i think so.
it will run maybe 4-5 dollars .
But once the the drug phenoxodiol finishing its testing ,
the drug targets prostate cancer protein.
once this is completed , share price could go anywhere. price could be anything . Its a holder , there in phase 3 so not long to go.